Invitation - Presentation of second quarter results
(Thomson Reuters ONE) -
Sobi's interim report for the second quarter of 2012 will be published on 19
July 2012 at 8.30 a.m. CET.
Conference call at 3.00 p.m. CET
Financial analysts and media are invited to a telephone conference at 3.00 p.m.
CET the same day hosted by CEO Geoffrey McDonough, COO Alan Raffensperger and
CFO Lars Sandström. The presentation will be held in English.
A recorded version will be available afterwards at www.sobi.com under Investors
& Media/Audio cast. Slides used in the presentation will also be available on
the web site under Investors & Media/Presentations.
Details for participation
Please call:
Sweden: +46 (0)8 505 629 32
UK: +44 (0)207 108 62 05
US: +1 866 676 58 70
Yours sincerely,
Åsa Stenqvist,
VP Communications and Investor Relations
Phone: +46 8 697 21 88
Swedish Orphan Biovitrum (Sobi)
Sobi is a leading integrated biopharmaceutical company dedicated to bringing
innovative therapies and services to improve the lives of rare disease patients.
The product portfolio is primarily focused on Inflammation and on Genetics and
Metabolism, and three late stage biological development projects within
hemophilia and neonatology. Sobi also has a portfolio of more than 40 products
which it commercializes on behalf of specialty and rare disease partners
companies. In 2011, Sobi had revenues of SEK 1.9 billion and around 500
employees. The share (STO: SOBI) is listed on NASDAQ OMX Stockholm. More
information is available at www.sobi.com.
Sobi press release 11 July in pdf format:
http://hugin.info/134557/R/1625883/520101.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Swedish Orphan Biovitrum AB (publ) via Thomson Reuters ONE
[HUG#1625883]
Unternehmensinformation / Kurzprofil:
Datum: 11.07.2012 - 12:00 Uhr
Sprache: Deutsch
News-ID 164343
Anzahl Zeichen: 2365
contact information:
Town:
Stockholm
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 163 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Invitation - Presentation of second quarter results"
steht unter der journalistisch-redaktionellen Verantwortung von
Swedish Orphan Biovitrum AB (publ) (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
